Related Experiment Video
Updated: Dec 5, 2025
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Cardiac Stem Cell-Loaded Delivery Systems: A New Challenge for Myocardial Tissue Regeneration
Antonia Mancuso1, Antonella Barone2, Maria Chiara Cristiano2
1Department of Health Sciences, Magna Græcia University of Catanzaro, Loc. Germaneto, 88100 Catanzaro, Italy.
Insights
Tissue engineering offers solutions for heart failure after myocardial infarction. Engineered patches and hydrogels improve stem cell delivery, but clinical application remains limited.
Area of Science:
- Regenerative medicine
- Biomaterials science
- Cardiovascular research
Background:
- Cardiovascular disease (CVD) is a leading cause of death.
- Post-myocardial infarction heart failure involves myocyte loss with limited regeneration.
- Regenerative biology and tissue engineering offer potential repair strategies.
Purpose of the Study:
- To review engineered patches and injectable hydrogels for cardiac tissue regeneration.
- To summarize advantages, novelty, and limitations of current stem cell delivery systems.
- To provide a perspective on the evolution of tissue engineering for clinical application.
Main Methods:
- Review of existing literature on stem cell delivery systems for cardiac repair.
- Analysis of strategies using injectable hydrogels and pre-formed patches.
- Evaluation of cell engraftment and integration with host myocardial tissue.
Main Results:
- Direct stem cell injection has limited efficacy due to the cardiac microenvironment and poor engraftment.
- Injectable hydrogels and engineered patches improve stem cell integration.
- Few stem cell delivery systems have translated to clinical practice despite promising features.
Conclusions:
- Engineered patches and hydrogels show promise for cardiac tissue regeneration.
- Overcoming limitations in current delivery systems is crucial for clinical translation.
- Future tissue engineering approaches should focus on optimizing delivery systems for widespread clinical use.
Abstract:
Cardiovascular disease (CVD) remains the leading cause of death in Western countries. Post-myocardial infarction heart failure can be considered a degenerative disease where myocyte loss outweighs any regenerative potential. In this scenario, regenerative biology and tissue engineering can provide effective solutions to repair the infarcted failing heart. The main strategies involve the use of stem and progenitor cells to regenerate/repair lost and dysfunctional tissue, administrated as a suspension or encapsulated in specific delivery systems. Several studies demonstrated that effectiveness of direct injection of cardiac stem cells (CSCs) is limited in humans by the hostile cardiac microenvironment and poor cell engraftment; therefore, the use of injectable hydrogel or pre-formed patches have been strongly advocated to obtain a better integration between delivered stem cells and host myocardial tissue. Several approaches were used to refine these types of constructs, trying to obtain an optimized functional scaffold. Despite the promising features of these stem cells' delivery systems, few have reached the clinical practice. In this review, we summarize the advantages, and the novelty but also the current limitations of engineered patches and injectable hydrogels for tissue regenerative purposes, offering a perspective of how we believe tissue engineering should evolve to obtain the optimal delivery system applicable to the everyday clinical scenario.
